Recently Featured

FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy for Hematologic Malignancies

July 22, 2026
The U.S. Food and Drug Administration (FDA) has granted approval for an allogeneic regulatory T cell-based immunotherapy that incorporates hematopoietic stem progenitor cells (HSPC) and T cells-vldq. This innovative therapy is specifically indicated for use in matched donor hematopoietic stem cell transplantation for adults suffering from hematologic malignancies. This approval marks a significant advancement in…

Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing

July 22, 2026
Basel, Switzerland, – Lonza, a leading contract development and manufacturing organization (CDMO), today announced plans to enhance its drug-linker center of excellence and expand payload-linker manufacturing capacity at its Visp site. The expansion will establish new commercial-scale capabilities for the manufacture of highly complex and highly potent active pharmaceutical ingredients (HPAPI) and ADC payload-linkers, reinforcing…

Anthropic Unveils Claude Science, Targeting Pharma Research Operations

July 21, 2026
SAN FRANCISCO — Anthropic, the artificial intelligence firm, on Tuesday announced the availability of Claude Science, an application that optimizes the company’s large language model for use in scientific laboratories and, especially, within the research operations of pharmaceutical companies. At a launch event here, Anthropic CEO Dario Amodei emphasized that until now, humans have wrestled…

Duke University Engineers Develop iPSC-Derived Retinal Endothelial Cells for Disease Research

July 21, 2026
Biomedical engineers at Duke University have successfully utilized induced pluripotent stem cells (iPSCs) to cultivate specialized retinal endothelial cells (iRECs), which are vital for maintaining retinal health. When these cells were injected into mouse models suffering from retinal diseases, they integrated into damaged tissues, facilitating blood vessel regeneration and restoring retinal function. This breakthrough not…

Ongoing Cases